Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1.

Autor: Velez JCQ; Department of Nephrology, Ochsner Health, New Orleans, Louisiana.; Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia.; HRS-HARMONY Consortium., Karakala N; HRS-HARMONY Consortium.; Division of Nephrology, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Tayebi K; Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia., Wickman TJ; Department of Nephrology, Ochsner Health, New Orleans, Louisiana., Mohamed MMB; Department of Nephrology, Ochsner Health, New Orleans, Louisiana.; Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia., Kovacic RA; Department of Nephrology, Ochsner Health, New Orleans, Louisiana., Therapondos G; Multiorgan Transplant Institute, Ochsner Health, New Orleans, Louisiana., Kanduri SR; Department of Nephrology, Ochsner Health, New Orleans, Louisiana.; Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia., Allegretti AS; HRS-HARMONY Consortium.; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Belcher JM; HRS-HARMONY Consortium.; Division of Nephrology, Department of Medicine, Yale University, New Haven, Connecticut.; Veterans Affairs Connecticut Healthcare, West Haven, Connecticut., Regner KR; HRS-HARMONY Consortium.; Division of Nephrology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Wentowski C; Department of Pulmonary and Critical Care Medicine, Ochsner Health, New Orleans, Louisiana.
Jazyk: angličtina
Zdroj: Kidney360 [Kidney360] 2023 Apr 01; Vol. 4 (4), pp. e448-e456. Date of Electronic Publication: 2023 Feb 10.
DOI: 10.34067/KID.0000000000000068
Databáze: MEDLINE